Home/ Supplements/ Vitamin K/ Krill Plus

Krill Plus

product on market Capsule MDLogic Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 20% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Superba2 krill and EFA blends provide omega-3 fatty acids, which have strong evidence for supporting cardiovascular health. Vitamin K plays a moderate role in bone metabolism and blood coagulation. Overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Krill Plus
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Liquid Capsule(s)
Serving Size
60
Servings
Fat/Fatty Acid
Product Type
20%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
6 Calorie(s)
Total Fat
0.5 Gram(s) (1% DV)
64 mcg (53% DV)
Within RDA (0.5× RDA) 275 studies (A:9, B:175)
Superba2 Krill
500 mg
Krill EFA Plus Blend
240 mg

Other Ingredients

Vegetable Cellulose D-Alpha Tocopheryl Acetate Lemon Oil
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Recommended Use: As a dietary supplement, take 1 liquid capsule daily or as recommended by a healthcare professional.

Warnings & Precautions

Warning: Consult with a health care professional before use and/or if you are pregnant, lactating, or undergoing treatment for a medical condition.

Do not exceed recommended dosage. Discontinue use if any adverse reactions occur and contact a health care professional. Do not use if seal under cap is broken or missing.

Keep out of reach of children.

Contains Crustacean Shellfish (Krill)

Formulation Notes

Contains NO milk, soy, egg, peanuts, tree nuts, wheat, gluten, rice, or yeast. NO artificial colors or flavors. NO toxic filters, including stearates and palmitates.

Lab tested for contaminates including heavy metals and mold.

Gluten Free

Featuring SuperBa2 Krill Oil Nature's Most Potent & Bioavailable Source of Omega-3

Support for heart, brain, joints & eyes

Additional Information

Store tightly closed in a cool, dry place.

Made in the USA from Global Ingredients Manufactured by a GMP Certified Company

Scan to Reorder

Metadata

Product Details

UPC / SKU8 97395 00231 9
DSLD Entry Date2023-11-22
Product TypeFat/Fatty Acid
FormCapsule
BrandMDLogic
DSLD ID299129
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.